Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 18 September 2012 | By Louise Zornoza •
Australia's Therapeutic Goods Administration (TGA) has opened a consultation on a proposed harmonized approach to the regulation of over-the-counter (OTC) medicines in New Zealand and Australia, in anticipation of the 2016 merger between TGA and New Zealand's Medsafe.
Full implementation of the proposed harmonized approach will require amending legislation in each of the two countries. Consequently, implementation of some aspects of the proposal is not expected to occur until the merged new agency, the Australian and New Zealand Therapeutic Products Agency (ANZTPA), comes into force. Pending the actual merger, Medsafe and the TGA will phase in the harmonized OTC regulatory framework locally. Comments on the proposal must be submitted by 7 November 2012.
The decision to merge Medsafe and the TGA into a new joint agency, ANZTPA, over a 5-year transitional period was announced on 20 June 2011 at the signing of a statement of intent by the Prime Ministers of both governments.
Tags: OTC, New Zealand, australia, regulations